MOCCIA, MARIALUISA
 Distribuzione geografica
Continente #
AS - Asia 139
NA - Nord America 87
SA - Sud America 40
EU - Europa 16
AF - Africa 4
Totale 286
Nazione #
US - Stati Uniti d'America 82
SG - Singapore 73
BR - Brasile 32
HK - Hong Kong 19
CN - Cina 17
VN - Vietnam 13
FR - Francia 6
DE - Germania 4
IN - India 4
AR - Argentina 3
CA - Canada 3
EC - Ecuador 3
AE - Emirati Arabi Uniti 2
GB - Regno Unito 2
ID - Indonesia 2
IQ - Iraq 2
JP - Giappone 2
MX - Messico 2
AT - Austria 1
BD - Bangladesh 1
BO - Bolivia 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
IT - Italia 1
LB - Libano 1
LT - Lituania 1
OM - Oman 1
TJ - Tagikistan 1
UA - Ucraina 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 286
Città #
Santa Clara 43
Singapore 38
Hong Kong 19
Beijing 11
Ashburn 6
Hanoi 5
Ho Chi Minh City 5
Düsseldorf 3
Lauterbourg 3
São Paulo 3
Baghdad 2
Belo Horizonte 2
Los Angeles 2
Montreal 2
Mumbai 2
New York 2
Quận Bình Thạnh 2
Tokyo 2
Atlanta 1
Bekasi 1
Betim 1
Brasília 1
Cairo 1
Campinas 1
Caraguatatuba 1
Carapicuíba 1
Cataguases 1
Caxias do Sul 1
Chandigarh 1
Chennai 1
Chicago 1
Constantine 1
Cotia 1
Criciúma 1
Denver 1
Diamantina 1
Dubai 1
Dushanbe 1
Feira de Santana 1
General La Madrid 1
Greenville 1
Guayaquil 1
Ibirité 1
Ilhéus 1
Irecê 1
Itapetinga 1
Johannesburg 1
Khulna 1
Kyiv 1
La Paz 1
Lajinha 1
Libreville 1
Live Oak 1
Magé 1
Marabá 1
Marigliano 1
Medellín 1
Nuremberg 1
Philadelphia 1
Phoenix 1
Phủ Lý 1
Pinheiral 1
Piracicaba 1
Pittsburgh 1
Poplar 1
Portoviejo 1
Portsmouth 1
Quilmes 1
Quilmes Oeste 1
Quixeramobim 1
Rio de Janeiro 1
Salinas 1
San Francisco 1
San Jose 1
Santa Catarina 1
Santa Elena 1
Seeb 1
Simonésia 1
Syracuse 1
São Bernardo do Campo 1
São José 1
São José do Rio Preto 1
Taquarituba 1
Tashkent 1
Tepic 1
The Dalles 1
Toronto 1
Vienna 1
Totale 222
Nome #
Identification of novel small molecule inhibitors of oncogenic RET kinase 40
Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology 38
Bioisosteric discovery of npa101.3, a second-generation ret/vegfr2 inhibitor optimized for single-agent polypharmacology 35
D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms 34
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: Design, synthesis and evaluation 34
Ret gene fusions in malignancies of the thyroid and other tissues 33
Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases 32
Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation 32
Discovery of N-Trisubstituted Pyrimidine Derivatives as Type I RET and RET Gatekeeper Mutant Inhibitors with a Novel Kinase Binding Pose 32
Totale 310
Categoria #
all - tutte 1.040
article - articoli 1.040
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20247 0 0 0 0 0 0 0 0 0 0 1 6
2024/2025167 7 0 14 3 41 6 14 13 11 9 27 22
2025/2026136 3 16 15 32 48 21 1 0 0 0 0 0
Totale 310